Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven A Narod

Showing results (231-240 of 544) with videos related to

Pageof 55
Sort By:
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 26, 2023
Germline Mutations in 12 Genes and Risk of Ovarian Cancer in Three Population-Based CohortsJoanne Kotsopoulos, Cassandra A Hathaway, Steven A Narod, et al.
Gynecologic Oncology|February 18, 2011
Frequencies of BRCA1 and BRCA2 mutations among 1,342 unselected patients with invasive ovarian cancerShiyu Zhang, Robert Royer, Song Li, et al.
Molecular Genetics & Genomic Medicine|December 22, 2017
Short report: Follow-up of Bahamian women with a BRCA1 or BRCA2 mutationSteven A Narod, Raleigh Butler, David Bobrowski, et al.
Clinical Chemistry|October 29, 2014
Chromosomal instability in cell-free DNA is a serum biomarker for prostate cancerEkkehard Schütz, Mohammad R Akbari, Julia Beck, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 24, 2014
Risk factors for ovarian cancers with and without microsatellite instabilityYakir Segev, Tuya Pal, Barry Rosen, et al.
Gynecologic Oncology|September 11, 2019
A comparison of ovarian cancer mortality in women with BRCA1 mutations undergoing annual ultrasound screening or preventive oophorectomyJacek Gronwald, Jan Lubinski, Tomasz Huzarski, et al.
Cancer Genetics and Cytogenetics|March 31, 2005
BRCA1 and pancreatic cancer: pedigree findings and their causal relationshipsHenry T Lynch, Carolyn A Deters, Carrie L Snyder, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|June 11, 2013
Risk factors for ovarian cancers with and without microsatellite instabilityYakir Segev, Tuya Pal, Barry Rosen, et al.
Annals of Surgical Oncology|March 24, 2021
Frequency of Contralateral Prophylactic Mastectomy in Breast Cancer Patients with a Negative BRCA1 and BRCA2 Rapid Genetic Test ResultKelly A Metcalfe, Andrea Eisen, Aletta Poll, et al.
Breast Cancer Research and Treatment|September 16, 2016
Ten-year survival in women with primary stage IV breast cancerLee Guek Eng, Shaheenah Dawood, Victoria Sopik, et al.
Pageof 55

Showing results (231-240 of 544) with videos related to

Sort By:
Pageof 55
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 26, 2023
Germline Mutations in 12 Genes and Risk of Ovarian Cancer in Three Population-Based CohortsJoanne Kotsopoulos, Cassandra A Hathaway, Steven A Narod, et al.
Gynecologic Oncology|February 18, 2011
Frequencies of BRCA1 and BRCA2 mutations among 1,342 unselected patients with invasive ovarian cancerShiyu Zhang, Robert Royer, Song Li, et al.
Molecular Genetics & Genomic Medicine|December 22, 2017
Short report: Follow-up of Bahamian women with a BRCA1 or BRCA2 mutationSteven A Narod, Raleigh Butler, David Bobrowski, et al.
Clinical Chemistry|October 29, 2014
Chromosomal instability in cell-free DNA is a serum biomarker for prostate cancerEkkehard Schütz, Mohammad R Akbari, Julia Beck, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 24, 2014
Risk factors for ovarian cancers with and without microsatellite instabilityYakir Segev, Tuya Pal, Barry Rosen, et al.
Gynecologic Oncology|September 11, 2019
A comparison of ovarian cancer mortality in women with BRCA1 mutations undergoing annual ultrasound screening or preventive oophorectomyJacek Gronwald, Jan Lubinski, Tomasz Huzarski, et al.
Cancer Genetics and Cytogenetics|March 31, 2005
BRCA1 and pancreatic cancer: pedigree findings and their causal relationshipsHenry T Lynch, Carolyn A Deters, Carrie L Snyder, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|June 11, 2013
Risk factors for ovarian cancers with and without microsatellite instabilityYakir Segev, Tuya Pal, Barry Rosen, et al.
Annals of Surgical Oncology|March 24, 2021
Frequency of Contralateral Prophylactic Mastectomy in Breast Cancer Patients with a Negative BRCA1 and BRCA2 Rapid Genetic Test ResultKelly A Metcalfe, Andrea Eisen, Aletta Poll, et al.
Breast Cancer Research and Treatment|September 16, 2016
Ten-year survival in women with primary stage IV breast cancerLee Guek Eng, Shaheenah Dawood, Victoria Sopik, et al.
Pageof 55